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Objective: To assess the long-term patency and clinical success of subintimal angioplasty in patients with limb-threatening
ischemia.
Methods: From 1999 through 2004, 29 patients with superficial femoral artery (SFA) or popliteal artery occlusion and rest
pain or tissue loss underwent subintimal angioplasty. Patients had subintimal wire placement followed by percutaneous
transluminal angioplasty and stent placement. From 1 to 10 stents were placed. Technical success required stenosis less
than 30% by arteriography, a velocity ratio less than 1.5 by duplex scan, and improvement of the ankle-brachial index
greater than 0.15. Follow-up duplex scanning was performed every 3 months for 2 years and then every 6 months
thereafter.
Results: Initial success was obtained in 26 (90%) of the 29 patients, with an improvement in the mean ankle-brachial index
of 0.25. Mean follow-up was 38 months (range, 28-54 months). During follow-up, 16 arteries reoccluded. Six of the 16
patients had recurrent symptoms, four required below-knee amputation, two required above-knee amputation, and four
died with an intact limb. After treatment failure, two patients had attempted tissue plasminogen activator (TPA), and
four had prosthetic tibial bypass. Overall, 15 patients died, and only 2 of the 14 who lived had a patent artery. One of the
two required percutaneous transluminal angioplasty of the recanalized artery. By life-table analysis, success was 85%, 64%,
18%, and 9% at 1, 2, 3, and 4 years, respectively. Periprocedural complications occurred in four patients. Of the 13
patients with wounds, six died (four healed), two were alive with healed wounds, and five had limb loss. Of 16 patients
with rest pain, 14 developed recurrent symptoms after reocclusion, 1 was alive without pain, and 1 underwent
amputation.
Conclusions: Subintimal angioplasty is technically successful in most patients, with few complications. Most procedures
provide short-term clinical success and have allowed for successful wound healing and temporary relief of rest pain.
However, late arterial patency is poor, with a high rate of symptom recurrence. Many patients will have recurrent pain,
and some will require major amputation. Nevertheless, limb-salvage rates are significantly better than arterial patency.
Intermediate-term patency is higher than that commonly reported for prosthetic bypass, and despite the lack of durable
long-term patency, the procedure offers an additional potentially effective therapeutic option in the treatment of patients
with limb-threatening ischemia and femoropopliteal occlusion. (J Vasc Surg 2006;43:513-9.)Subintimal angioplasty or percutaneous intentional ex-
traluminal recanalization was initially described by Bolia
et al1 almost 20 years ago. The procedure was initially used
to treat high-risk patients with limb-threatening ischemia
who were not considered acceptable candidates for opera-
tive revascularization. Since that time, as the procedure has
gained more widespread acceptance, its use has dramati-
cally increased, and the indications for the approach have
continually expanded. Some institutions now use the pro-
cedure to treat patients with limb-threatening ischemia
who are suitable candidates for arterial reconstruction,
some use subintimal angioplasty as primary therapy for
patients with intermittent claudication, and others treat
patients with extremely limited life expectancy on the basis
of the assumption that the relatively low risk of death or
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Since the initial report, thousands of additional patients
have been treated with the procedure. Although most of
the early studies came from European centers, several re-
cent studies from the United States have been reported.
Unfortunately, indications for the technique continue to
vary, the procedure technique is still not standardized,
variable reporting standards and criteria for success are
used, and long-term data remain very limited.
In our initial report 3 years ago, our goal was to
determine the safety and technical feasibility of subintimal
angioplasty in patients with femoropopliteal arterial occlu-
sion, evaluate short-term patency and limb salvage, and
better define indications for this approach.2 We concluded
that subintimal angioplasty was technically possible in most
patients with femoropopliteal occlusion and that it had a
relatively low incidence of complications. When successful,
this approach resulted in an improvement in the ankle-
brachial index (ABI), usually provided for effective relief of
rest pain, and allowed for wound healing. The procedure
resulted in good short-term patency of the recanalized
artery, but long-term data were unknown. The value of
routine duplex surveillance was unknown, and further stud-
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angioplasty could be recommended as an effective alterna-
tive to arterial bypass. This study was designed to assess
intermediate-term patency and to help determine the assis-
tance this procedure may offer in the treatment of patients
with chronic limb ischemia.
METHODS AND MATERIALS
Approval for this study was obtained from the Univer-
sity of Utah Institutional Review Board. From 1999
through 2003, 29 patients underwent subintimal angio-
plasty for treatment of femoropopliteal occlusive disease
and limb-threatening ischemia at the Veterans Administra-
tion Salt Lake City Health Care System. Patients with a
patent SFA or popliteal artery and one or more stenoses
were treated with traditional balloon angioplasty. Subinti-
mal angioplasty was reserved for patients with complete
occlusion because intraluminal wire and catheter passage
would be difficult and patency would be expected to be less
in these patients with traditional percutaneous transluminal
angioplasty (PTA). These patients were not good candi-
dates for prosthetic bypasses because of unfavorable anat-
omy and significant medical comorbidities.
After clinical examination identified individuals with
infrainguinal disease and limb-threatening ischemia, ABIs
were obtained to document the severity of ischemia and
provide baseline hemodynamic data for follow-up. Patients
had a venous duplex scan to determine whether a suitable
autologous vein was available. In addition, the patients had
a cardiac evaluation according to criteria established by the
American Heart Association to help assess the risk of oper-
ation. Diagnostic arteriography was performed by an inter-
ventional radiologist, and results were reviewed by the
vascular surgeon and radiologist to determine whether the
pattern of disease was suitable for either operative or endo-
vascular therapy.
Our technique for the procedure has been previously
described.2 All recanalizations were performed in the en-
dovascular suite. Either contralateral or ipsilateral femoral
artery puncture was used, depending on the distance to the
occluded segment. Brachial or axillary puncture was not
used. The entire length of the dissection was stented, but
stents were not placed proximal or distal to the re-entry
points. Intracoil stents were used exclusively in these pa-
tients. Repeat PTA of the stents was performed to secure
their location, and a completion angiogram and duplex
scan were then obtained. Although proximal or distal arte-
rial reconstruction may be performed during the same
hospitalization, this approach has not been used at our
institution. Thrombolytic therapy of the superficial femoral
artery or popliteal artery was attempted before subintimal
angioplasty in eight patients. Patients were selected for
thrombolysis if their clinical history suggested recent occlu-
sion with relatively fresh thrombus and the diagnostic
arteriogram indicted that thrombolysis had a reasonable
likelihood of success. Thrombolysis was usually attempted
for 24 to 36 hours, but the duration varied depending on
clinical response. However, in no patient in this series wasthrombolysis successful in restoring complete patency of
the true lumen because these patients then would have had
either no further treatment or traditional PTA. Subintimal
angioplasty was reserved for patients with a residual occlu-
sion after thrombolysis. Patients with prior thrombolysis
were not treated differently during the subintimal angio-
plasty procedure.
Patients were treated with aspirin before diagnostic
arteriography and subsequent subintimal angioplasty and
were continued on aspirin after the procedure. Eleven
patients were receiving warfarin therapy and were contin-
ued on the drug during follow-up. All patients were con-
tinued on preprocedure medications during follow-up, but
lipid-lowering medications (hydroxymethylglutaryl coen-
zyme A reductase inhibitor drugs), angiotensin-converting
enzyme inhibitors, -blockers, and other antiplatelet agents
(including clopidogrel) were not routinely started. Patients
were maintained on an integrelin infusion for 24 hours in
the intensive care unit after the procedure.
Follow-up on patients who underwent subintimal angio-
plasty included serial clinical examinations, ABI determina-
tions, and duplex scanning of the treated artery every 3
months for the first 2 years and then every 6 months thereaf-
ter. However, repeat duplex scans were obtained sooner for
recurrent symptoms that suggested arterial occlusion.
Arteriograms were selectively obtained when there was
evidence of a hemodynamically significant stenosis identi-
fied by duplex scan that was suitable for further interven-
tion. Our duplex criterion for a significant stenosis is a
velocity ratio greater than 3.0 comparing the treated seg-
ment with the proximal artery. This is based on our prior
studies that correlated duplex velocities with the degree of
stenosis in vein grafts because relatively limited data are
available in recanalized and stented vessels after subintimal
angioplasty. This determination was made on an individual
basis and in part depended on clinical examination results
and the ABI. Arteriograms were not obtained if the
patient was not a suitable candidate for either arterial
bypass or thrombolytic therapy because of limited life
expectancy, underlying medical comorbidities, advanced
renal insufficiency, or patient preference. In addition,
arteriograms were not obtained if the clinical history indi-
cated that the duration of occlusion was more than 3 to 4
weeks, because the likelihood of success with thrombolytic
therapy was low.
Technical success required (1) stenosis less than 30% on
completion arteriography, (2) a velocity ratio on duplex
scan less than 1.5 comparing the treated artery with the
proximal patent vessel, and (3) improvement in the ABI to
0.15 or higher or, for patients with calcified or noncom-
pressible vessels, an improvement in tibial waveforms.
Failure was defined as reocclusion of the treated arterial
segment. No case in this study was classified as a treatment
failure solely on the basis of duplex scan evidence of recur-
rent stenosis or of a decrease in the ABI. The Kaplan-Meier
product-limit method was used to create life-table plots
with failure equal to the time from procedure to recurrence.
Results were analyzed and reported in accordance with the
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lar procedures. Treatment outcome was based on intent to
treat. To allow for statistical analysis, patients who did not
undergo successful subintimal angioplasty were recorded as
treatment failure at time 0.
RESULTS
The 29 patients (28 men and 1 woman) ranged in age
from 48 to 86 years (mean, 71 years). Cardiovascular risk
factors are listed in Table I. Fourteen patients had a prior
bypass. The indication for subintimal angioplasty was rest
pain in 16 patients (55%) and a nonhealing wound or
gangrene in 13 (45%). The mean preprocedure ABI for all
patients was 0.31.
Of the 29 individuals in this series, 20 patients had
complete or segmental SFA occlusion combined with pop-
liteal occlusion and had tibioperoneal trunk or tibial artery
reconstitution, 8 had complete or partial SFA occlusion
with a patent popliteal artery, and 1 had a patent femoro-
popliteal segment but proximal occlusion of all 3 tibial
arteries. Overall, 3 tibial arteries were patent in 3 patients, 2
were patent in 16, 1 in 9, and no crural artery in 1 (although
supramalleolar reconstitution was present). No patient had
hemodynamically significant inflow disease at the time of
subintimal angioplasty, but most had significant outflow
disease. This may help explain the low ABI and limb-
threatening ischemia in these patients.
If recanalization were not attempted, these patients
without a suitable vein would have required prosthetic
infrageniculate bypass or major amputation. In addition to
the lack of a good autogenous conduit, 6 of the 29 patients
had an ejection fraction less than 15%, 5 others had signif-
icant coronary artery disease on coronary arteriography,
and 2 had cancer but refused amputation.
Subintimal angioplasty was technically successful in 26
(90%) of the 29 cases as determined by the criteria defined
Table I. Demographic information, cardiovascular risk
factors, and lesion characteristics
Variable Number Percent
Male 28 97
Thrombolysis 8 28
# patent tibial arteries
0-1 10 35
2 16 55
3 3 10
Artery treated
SFA 8 28
SFA and Popliteal 20 69
Tibial 1 3
Diabetes mellitus 16 55
Hypertension 22 76
Coronary artery disease 24 83
Cigarette use 17 59
Renal insufficiency 8 28
Prior arterial bypass 14 48
SFA - superficial femoral artery.previously. Recanalization could not be performed in threecases because of inability to maintain patency of the recana-
lized artery with angioplasty and stenting despite successful
wire and catheter passage. Of the three patients who expe-
rienced a technical failure, two had an above-knee amputa-
tion (AKA) and one died without further therapy.
Four patients (13.7%) had complications related to the
procedure: one patient had a contralateral groin hematoma
that necessitated operative evacuation, one had an ipsilat-
eral groin hematoma that necessitated blood transfusion,
one had distal embolization that was treated successfully
with thrombolytic therapy, and one had a fatal myocardial
infarction. This occurred 2 days after the procedure in a
patient with severe coronary artery disease who was not a
candidate for either coronary or infrainguinal bypass.
The mean follow-up on the 29 patients was 38 months
(range, 28-54 months). During follow-up, 15 patients
died, and 14 remained alive. Of the 15 patients who died, 4
had reocclusion of the treated artery before death, and 11
had patent arteries. In the 14 patients who were alive at last
follow-up, only 2 recanalized arteries were patent, and 12
were occluded. Patency in one of the two arteries was
achieved with thrombolysis and repeat angioplasty.
Independent variables, demographic factors, and car-
diovascular risk factors were not statistically analyzed with
regression analysis because of the high likelihood of a type
II error. However, the number of patent tibial arteries, the
length of occlusion, and whether the SFA, popliteal, or
both arteries were occluded did not clearly correlate with
outcome. The number of stents reflected the length of
occlusion, but this did not correlate with outcome. There
was no significant difference in outcome between patients
treated with aspirin and those treated with aspirin and
warfarin. There was no clear difference in outcome between
patients treated with or without preliminary thrombolysis.
Overall, therefore, 16 (55%) of 29 arteries occluded
during follow-up. Six of the 16 patients had recurrent rest
pain, 6 required major amputation (4 below-knee amputa-
tions and 2 AKAs), and 4 had prosthetic tibial artery
bypasses. By life-table analysis, the primary patency was
85% at 1 year (SE, 6.1%), 64% at 2 years (SE, 11.0%), 18%
Fig 1. Life-table plot of primary patency for 29 patients treated
with subintimal angioplasty.at 3 years (SE, 14.7%), and 9% at 4 years (Fig 1). Two of the
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than 3.0 before occlusion, but both experienced occlusion
before further therapy. One of the 16 patients had a de-
crease in the ABI greater than 0.15, but the patient did not
have a velocity ratio greater than 3.0 on duplex scan and
had no further intervention.
Limb-salvage rates were better than arterial patency.
Limb-salvage was 95% (SE, 4.4%), 80% (SE, 10.8%), 80%
(SE, 16.0%) and 32% (SE, 18.6%) at 1, 2, 3, and 4 years,
respectively (Fig 2). All 15 patients who died had an intact
extremity.
Results were also analyzed according to the indication
for intervention and the presenting symptom (Table II). Of
the 13 patients with wounds, 6 died, and 4 (66%) of the 6
had healed wounds. Seven of the 13 patients were alive: 2
with healed wounds and 5 with major amputation. Of 16
patients with rest pain, 14 (88%) developed recurrent rest
pain after reocclusion, 1 was alive without pain, and 1 had
amputation.
Secondary intervention was performed in seven pa-
tients after occlusion of the treated arterial segment. As
noted previously, four patients had a prosthetic tibial artery
bypass. Two grafts remained patent, and two occluded. Of
the remaining three patients, one had successful thrombol-
ysis and repeat angioplasty, one had unsuccessful throm-
bolysis, and one had unsuccessful repeat PTA without
thrombolysis.
DISCUSSION
Subintimal angioplasty is rapidly becoming an estab-
lished procedure in the treatment of lower extremity isch-
emia. This study confirms our previous findings, as well as
the findings from other centers, that short-term patency
and limb salvage rates up to 2 years are excellent, even in
severely ill patients with chronic limb-threatening ischemia.
This indicates that the procedure will continue to have an
important role in the treatment of these patients, and
results are likely to improve as more experience and exper-
tise are acquired. In our experience, however, arterial pa-
tency decreased markedly after 2 years. Of the 14 patients
Fig 2. Life-table plot of limb salvage for 29 patients treated with
subintimal angioplasty.who remained alive, the significant majority developedrecurrent symptoms or required major amputation. Never-
theless, limb salvage was much better than patency at the
same intervals, in part because of the high overall mortality
in these patients, many of whomdied with an intact extrem-
ity despite an occluded artery. The short-term mortality in
this group of patients with chronic limb ischemia and
contraindications to autogenous bypass is high. With a
mean follow-up of 38 months, more than half of our
patients had died. Other studies also found that mortality
was in excess of 50% at 3 years.
On the basis of our study, subintimal angioplasty can-
not be recommended as a durable therapy in patients with
chronic limb ischemia and with a good life expectancy
because symptomatic recurrence is likely. Patients with rest
pain did receive a temporal benefit while the artery re-
mained patent, but recurrent pain was common. Most,
however, have not yet required major amputation. Simi-
larly, although patients with gangrene may still come to
amputation, only six patients in our series required below-
knee amputation or AKA, thus suggesting that the proce-
dure may help to prevent limb loss in patients with a limited
life expectancy. Because our study reflects a Veterans Ad-
ministration population with significant medial comorbidi-
ties, care must be taken in extrapolating these results to
other patient groups.
Most other reports have also found that limb-salvage
rates are higher than arterial patency. For example, Lazaris
et al3 noted 40% patency at 3 years and 90% limb salvage at
the same interval. Shaw et al4 noted 57% patency with 92%
limb salvage at 12 months, and Tisi et al5 reported 27%
patency with 86% limb salvage at the same interval.
For patients without medical contraindications to open
surgery, prosthetic bypass is an alternative. Nevertheless,
the 64% patency rate with subintimal angioplasty at 2 years
is higher than that reported for most series of patients with
limb-threatening ischemia necessitating prosthetic infra-
geniculate bypass. This suggests that the procedure may be
a superior alternative in some patients because it avoids a
general anesthetic, has fewer perioperative complications,
and has a reasonable short-term limb salvage rate. In addi-
tion, the procedure may have a greater role especially if
results continue to improve with improvements in equip-
ment, greater experience, better adjunctive medication,
and improved identification of patient and lesion factors
associated with success. Clearly, the limb-salvage rate re-
ported in other studies suggests that the procedure may
play an important role in reducing the need for amputation
in these patients. Our limb salvage rate of 95% at 1 year and
80% at 3 years is clearly superior to the rates in most studies
that have used prosthetic bypass for critical limb ischemia.
Although this rate decreased to 32% at 4 years, most
patients had already died by this time.
Our experience does support the concept that failed
recanalization does not alter or jeopardize subsequent by-
pass. It was our observation in the four patients who
underwent subsequent prosthetic bypass that the proce-
dure was similar to what would have been required if
subintimal angioplasty had not been undertaken. Anecdot-
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vessels or collaterals in patients after subintimal angioplasty
occlusion. In fact, it has been postulated that the procedure
may open up previously occluded collateral vessels.6 For
successfully treated patients, the mean improvement in ABI
in our experience of 0.25 is similar to the mean improve-
ment in other articles.4 This suggests a similar hemody-
namic benefit.
We continue to support the notion that prior bypass is
not a contraindication to subintimal angioplasty. Fourteen
patients in our experience had experienced treatment fail-
ure with one or more previous bypasses in the affected
extremity, and technical success was similar in these pa-
tients. Other reports have been conflicting. Lipsitz et al7,8
reported that bypasses performed in this setting remained
patent. However, Walker et al,9 reporting on 12 patients
who underwent subintimal angioplasty of a native artery
after failed bypass, found that 7 procedures were technically
successful but that only 1 remained patent at 4 weeks.
We are concerned that some of the late arterial occlu-
sions may have resulted from suboptimal use of adjunctive
medication. Unfortunately, there is no consensus regarding
appropriate adjunctive therapy, and we found no studies
that compared alternative regimens. Systemic hepariniza-
tion during the procedure is widely used, and most studies
have used antiplatelet agents during follow-up in an at-
tempt to maintain patency.1,4,10,11 Bolia et al1 also used
tolazoline and nitroglycerin to help control periprocedural
vasospasm, but this should not affect late failure. All of our
patients were receiving aspirin before the procedure and
during follow-up, received systemic and local heparin dur-
ing the procedure, and were maintained on integrelin dur-
ing the critical initial 24 hours.
We did not routinely use other adjunctive medications.
However, Florenes et al,12 and Tefera et al13 independently
suggested that the routine use of aspirin and clopidogrel
may improve results, and London et al10 found that aspirin
was a significant but dependent factor associated with pa-
tency. Lipsitz et al,14 reporting the longest experience in
this country, recommended aspirin and clopidogrel for only
Table II. Final clinical outcome based on indication for su
Non-healing wound/gangrene-13 patients
Not hea
Died (6)
Alive (7)
Rest pain-16 patients
symptom
Died (9)
Alive (7)
Overall-29 patients
ar
Died (15) (52%)
Alive (14) (48%)
a
Died (15)
Alive (14)6 weeks after the procedure. Hynes et al15 recommendedaspirin, clopidogrel, hydroxymethylglutaryl coenzyme A
reductase inhibition, and a cardioselective -blocker for 1
year and noted that this regimen statistically improved
overall outcome. Patency rates, however, were not pro-
vided. Given the high number of failures in our study,
additional therapy including clopidogrel and possibly low-
molecular-weight heparin or warfarin may decrease the
number of late occlusions.
The interval to occlusion and etiology for failure are
important considerations in helping to determine the opti-
mal role and frequency of surveillance. In this study, we
found that arterial patency was 85% at 1 year but only 18%
at 3 years and 9% at 4 years. In other studies, most throm-
bosis has usually occurred during the first 12 to 24 months,
but few studies have follow-up beyond this time period.
Yilmaz et al16 reported 57% primary assisted patency at 12
months, and this declined to 19% at 24 months. Primary
patency at 24 months was only 9%.14,16 In contrast to our
experience, however, that study found that most occlusions
occurred during the first 6months and concluded that early
measures were the most important in obtaining success.14,16
Although there are few studies with longer-follow-up, they
suggest that late thrombosis is uncommon and may be
prevented with reintervention.13
In our study, seven patients had reintervention after
occlusion of the treated arterial segment. Four patients had
prosthetic tibial artery bypass, and three had repeat endo-
vascular procedures. One patient had successful thrombol-
ysis and repeat angioplasty, one had unsuccessful throm-
bolysis, and one had unsuccessful repeat PTA. The major
difference between our study and some others is that we
were not aggressive in obtaining arteriograms for patients
with possible hemodynamically significant stenosis. As we
noted previously, this was for a variety of reasons, including
patient preference, a long duration of occlusion, or major
contraindications to successful reintervention. This may
explain why our patency decreased over time and suggests
that a more aggressive surveillance protocol may be more
effective in maintaining patency.
Florenes et al12 reported a 54% 5-year primary assisted
imal angioplasty
amputation Healed Amputation
4 0
2 5
amputation asymptomatic Amputation
0 0
1 1
atent artery occluded
8%) 4 (14%)
%) 12 (41%)
ation no amputation
15
8bint
led/
2
7
atic/
9
6
tery p
11 (3
2 (7
mput
0patency rate, but 17 of the 116 claudicants in that study had
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of more than 50%. Of the 17 arteries treated, 2 reoccluded,
and the authors concluded that good surveillance was
critical. Laxdal et al11 also used repeat PTA for stenosis
greater than 50% and performed 11 reinterventions on the
124 patients in their study. They obtained a primary as-
sisted patency of only 31% at 18 months, however, and the
results were even more dismal in individuals with chronic
limb ischemia. Lazaris et al3 did not use routine follow-up
duplex scan or ABI tomonitor patency, but 11 (33%) of the
34 patients in their study needed a follow-up procedure.
Even with this high rate of reintervention, patency was only
40% at 3 years. Hynes et al15 have combined a decrease in
the ABI greater than 0.15 with stenosis of greater than 50%
on duplex scan as an indication for reintervention, but the
success of this approach was not reported. These reports
using reintervention cautioned, however, that prophylactic
redilation has not proven to be of benefit.12
We placed stents across the entire recanalized segment,
but we are concerned that this approach may have contrib-
uted to late failure because some studies that did not use
stents have reported better outcomes. In addition, al-
though subintimal angioplasty may successfully open col-
lateral vessels, it has been found that stents may mitigate
this effect, thus jeopardizing collaterals and, potentially,
patency.6 Our procedure differs from the initial procedure
described by Bolia et al1 in that we stented the entire
segment. Most of our procedures were performed 4 or 5
years ago, when data regarding the role of stents were
unclear. We no longer recommend stenting the entire
length of the dissection, on the basis of our experience and
that of others. Because the role of stents and themechanism
and risk of reocclusion had not been clearly determined at
that time, we thought that stents might help to maintain
patency.
Some other studies have also used routine stent place-
Table III. Reported patency of subintimal angioplasty
Author (year) Limbs FU range mo
London (1994) 200
Reckers (1994) 40
Nydahl (1997) 28 8-48
McCarthy (2000) 69 1-29 (
Vraux (2000) 40 (
Yilmaz (2001) 67
Ingle (2002) 70 1-36
Tisi (2002) 158
Shaw (2002) 50 5-10 (
Lipsitz (2003) 39
Treiman (2003) 25 4-36 (
Laxdal (2003) 124
Lazaris (2004) 99 20 (
Florenes (2004) 116 41 (
*- clinical success, not documented arterial patency.
@- primary patency at 6 months.
- primary patency at 24 months.
#- primary assisted patency at 18 months.ment, whereas some have stented selectively for complica-tions or suboptimal results.14 Some centers have not used
stents out of concern that they may increase myointimal
hyperplasia.6,7,13,15,17,18 Hynes et al15 found that stents
did not improve patency, but Yilmaz et al16 found no
difference in patency between patients treated with or
without stents. Sakethoo et al19 used routine stent place-
ment with excellent short-term results. In comparison with
other reports that did not use routine stenting, our patency
rates are inferior, and this suggests a potentially detrimental
effect of routine stent placement.
Our previous article concluded that identifying patients
who are most likely to benefit from the procedure was
difficult and that the ability to draw significant conclusions
from demographic variables, cardiovascular risk factors, and
other lesion characteristics was limited because of the few
arteries that reocclude during short-term follow-up. Our
current results again limit the ability to provide this infor-
mation: now because of the high failure rate and inability to
maintain patency. Our small numbers do not allow for
statistical analysis because of the likelihood of a type II
error. However, it does not seem that any independent
variable is significantly associated with success.
Arterial calcification, poor runoff, diabetes, treatment
for chronic limb ischemia as opposed to claudication, and
lesion length are the variables most frequently postulated to
affect patency. Some articles suggest that calcification in the
wall of the occluded artery makes recanalization difficult
and predisposes to technical failure, but others could not
confirm this effect.20 Although intuitively, occlusions are
thought to be more difficult to treat than stenosis, results
have been conflicting.5,11,14,16,17 All of our patients were
treated for chronic limb ischemia, and we found primary
patency to be 18% at 3 years.
These poor results in treating patients with chronic
limb ischemia are similar to the 27% primary assisted pa-
tency rate at 12 months reported by Tisi et al5 and the 24%
mean)
1 year primary
assisted patency
3 year primary
assisted patency
71% 58%
59% —
53% —
60% —
56% —
57% 19%
80%* —
27% —
57%@ —
64% 51%
92% —
37% 31%#
74%* 40%*
62% 57%nths (
8)
10)
7.9)
13)
3-32)
0-79)primary assisted patency rate at 6 months reported by
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durable patency is slightly higher in patients treated for
claudication. Twelve-month primary assisted patency rates
in series that have primarily treated claudicants have ranged
from 37% to 83%,14 and recent articles have not shown
significantly higher rates than earlier published studies.
CONCLUSION
As has been previously reported, subintimal angioplasty
is technically successful in most patients, with few compli-
cations. Most procedures provide short-term clinical suc-
cess and have allowed for successful wound healing and
temporary relief of rest pain. However, late arterial patency
is poor, with a high rate of symptom recurrence. Many
patients will have recurrent pain, and some will require
major amputation. In comparison with other studies that
did not use routine stenting, our patency rates were inferior,
thus suggesting a potentially detrimental effect of routine
stent placement. Nevertheless, limb-salvage rates were signif-
icantly better than arterial patency. Intermediate-term pa-
tency was higher than that commonly reported for pros-
thetic bypass, and despite the lack of durable long-term
patency, the procedure offers an additional potentially ef-
fective therapeutic option in the treatment of patients with
limb-threatening ischemia and femoropopliteal occlusion. 19
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